US Patent Issued to SEEGENE on Aug. 19 for "Method for determining the presence or absence of M. tuberculosis, M. bovis and M. bovis BCG in a sample" (South Korean Inventors)

ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,391,997, issued on Aug. 19, was assigned to SEEGENE INC. (Seoul, South Korea).

"Method for determining the presence or absence of M. tuberculosis, M. bovis and M. bovis BCG in a sample" was invented by Kwang-Il Lee (Seoul, South Korea) and Mi Seon Lee (Gyeonggi-do, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a method for determining the presence or absence of M. tuberculosis, M. bovis, and M. bovis BCG in a sample comprising a nucleic acid molecule. A method according to the present invention can detect the individual presence of M. tuberculosis, M. bovis, and M. bovis BCG, and the co-presence of two there...